Phase II, randomized study of concomitant chemoradiotherapy followed by surgery and adjuvant capecitabine plus oxaliplatin (CAPOX) compared with induction CAPOX followed by concomitant chemoradiotherapy and surgery in magnetic resonance imaging-defi - Wikidata - wikimedia - TriplyDB

Phase II, randomized study of concomitant chemoradiotherapy followed by surgery and adjuvant capecitabine plus oxaliplatin (CAPOX) compared with induction CAPOX followed by concomitant chemoradiotherapy and surgery in magnetic resonance imaging-defi

Phase II, randomized study of concomitant chemoradiotherapy followed by surgery and adjuvant capecitabine plus oxaliplatin (CAPOX) compared with induction CAPOX followed by concomitant chemoradiotherapy and surgery in magnetic resonance imaging-defi

http://www.wikidata.org/entity/Q34615588

about

Neoadjuvant chemoradiation therapy and pathological complete response in rectal cancer Neoadjuvant chemotherapy without radiotherapy for locally advanced rectal cancer Organ Preservation in Rectal Adenocarcinoma: a phase II randomized controlled trial evaluating 3-year disease-free survival in patients with locally advanced rectal cancer treated with chemoradiation plus induction or consolidation chemotherapy, and Postoperative chemotherapy use after neoadjuvant chemoradiotherapy for rectal cancer: Analysis of Surveillance, Epidemiology, and End Results-Medicare data, 1998-2007 Can we eliminate neoadjuvant chemoradiotherapy in favor of neoadjuvant multiagent chemotherapy for select stage II/III rectal adenocarcinomas: Analysis of the National Cancer Data base.Addition of bevacizumab to XELOX induction therapy plus concomitant capecitabine-based chemoradiotherapy in magnetic resonance imaging-defined poor-prognosis locally advanced rectal cancer: the AVACROSS study Evaluation of capecitabine and oxaliplatin administered prior to and then concomitant to radiotherapy in high risk locally advanced rectal cancer.Can dosimetric parameters predict acute hematologic toxicity in rectal cancer patients treated with intensity-modulated pelvic radiotherapy?Efficacy and safety of neoadjuvant chemotherapy with oxaliplatin, 5-fluorouracil, and levofolinate for T3 or T4 stage II/III rectal cancer: the FACT trial.Neoadjuvant therapy before surgical treatment Adjuvant chemotherapy Abdominoperineal excision following preoperative radiotherapy for rectal cancer: unfavorable prognosis even with negative circumferential resection margin Long-term results of a randomized trial in locally advanced rectal cancer: no benefit from adding a brachytherapy boost.Therapeutic approaches in the management of locally advanced rectal cancer.The emerging role of neoadjuvant chemotherapy for rectal cancer The role of capecitabine in locally advanced rectal cancer treatment: an update.Peri-operative chemotherapy in the management of resectable colorectal cancer pulmonary metastases.Adjuvant therapy sparing in rectal cancer achieving complete response after chemoradiation Phase II trial evaluating the feasibility of interdigitating folfox with chemoradiotherapy in locally advanced and metastatic rectal cancer.Neoadjuvant-intensified treatment for rectal cancer: time to change?Gender-specific acute organ toxicity during intensified preoperative radiochemotherapy for rectal cancer.Neoadjuvant treatment in rectal cancer: actual status.Tumor Volume Reduction Rate Predicts Pathologic Tumor Response of Locally Advanced Rectal Cancer Treated with Neoadjuvant Chemotherapy alone: Results from a Prospective Trial Bevacizumab and Combination Chemotherapy in rectal cancer Until Surgery (BACCHUS): a phase II, multicentre, open-label, randomised study of neoadjuvant chemotherapy alone in patients with high-risk cancer of the rectum.CoCStom trial: study protocol for a randomised trial comparing completeness of adjuvant chemotherapy after early versus late diverting stoma closure in low anterior resection for rectal cancer.Current status of intensified neo-adjuvant systemic therapy in locally advanced rectal cancer.The current state of targeted agents in rectal cancer.Advances and challenges in treatment of locally advanced rectal cancer.Effect of adding mFOLFOX6 after neoadjuvant chemoradiation in locally advanced rectal cancer: a multicentre, phase 2 trial.Treatment of locally advanced rectal cancer: controversies and questions.Pretreatment high-resolution rectal MRI and treatment response to neoadjuvant chemoradiation Extramural depth of rectal cancer tumor invasion at thin-section MRI: predicting treatment response to neoadjuvant chemoradiation.Critical role of bevacizumab scheduling in combination with pre-surgical chemo-radiotherapy in MRI-defined high-risk locally advanced rectal cancer: Results of the BRANCH trial Clinical practice guidelines for the surgical treatment of rectal cancer: a consensus statement of the Hellenic Society of Medical Oncologists (HeSMO)A phase II trial of neoadjuvant IMRT-based chemoradiotherapy followed by one cycle of capecitabine for stage II/III rectal adenocarcinoma Surgery for Locally Advanced T4 Rectal Cancer: Strategies and Techniques.The status of targeted agents in the setting of neoadjuvant radiation therapy in locally advanced rectal cancers.Phase II Study of Preoperative Capecitabine and Oxaliplatin-based Intensified Chemoradiotherapy With or Without Induction Chemotherapy in Patients With Locally Advanced Rectal Cancer and Synchronous Liver-limited Resectable Metastases.Predictors of circumferential resection margin involvement in surgically resected rectal cancer: A retrospective review of 23,464 patients in the US National Cancer Database.Effectiveness of image-guided radiotherapy for locally advanced rectal cancer.

P2860

Q26796352-B80D53D2-35CF-47F8-961E-1A4C63C5FA94 Q27003878-F9279FB9-9CA0-45C9-A069-8B74F9A2EECB Q30370343-A6B80721-4391-464B-83C3-CF0F1AD00AF5 Q30744596-6F9DF17E-B4BF-4BD9-9658-D1F86451772B Q31138958-FB750DC6-498B-4479-8D22-560BF64D5D56 Q33394804-E98D839C-FD94-49E0-9146-DFF4E4C77B66 Q33411783-099C74C4-ED18-450A-9500-563626666053 Q33424898-42E80CDE-0061-4697-BA90-359BFD34A9F6 Q33438899-85783C34-7E27-4AD9-B39D-2C04D040AC58 Q33697924-B8D6FB7C-EB49-4658-A6A4-C84DB790B35F Q33698724-1C6B0EE1-09C5-412F-9F0B-B16B86ED45C2 Q33958747-F1E3E92C-E024-4123-B5A9-F0E63F09152C Q34156692-6604F077-AE02-4071-910A-DFE05490CB24 Q34234928-8CADD746-2BF6-4E02-9C4B-DDF8F8786A62 Q34234935-BDE1412F-D8A7-42EE-ADE8-847D9685478F Q34276823-A520F384-2901-4C78-976C-F54569B6AD62 Q34360237-B5A39E29-FFFC-4DFB-A068-ECCEF7A8FCA7 Q34499179-9CBF8160-030E-4C6F-AAC1-615CEB233394 Q34499632-2AB6855C-395B-45C2-B5B8-8781BD99948A Q34743672-FD9A0984-BB15-49AC-8BAF-25150E9A0CEB Q35584836-98807BE1-323C-45A6-B0D3-65C04C7FA179 Q35687452-C5F2096F-DE2E-4923-84AC-A1871F24A423 Q35739533-29F73DFD-0A51-49E9-A94A-66C8F7550E76 Q35817933-FD176279-333E-4F14-8D73-0D8FBE20E94F Q35847605-4AC961FE-81A9-4B29-AEB6-EB862243098E Q35987944-78C6241E-69F1-4AB4-B82C-CD60D6E4EA41 Q35996651-9061AE95-4E23-4AFC-88BA-3B6248229940 Q36025983-03553CE3-6313-414B-8A4F-EC9E5D5A0884 Q36348179-D307130A-25EF-4B01-BB08-E6FE278527B2 Q36351882-EBBB8261-ACAF-4A55-BE27-942977F5BA92 Q36537952-6AF28AED-9EE1-42E5-9731-4F759641604A Q36557565-680494B0-7689-4758-BD43-B3241C0EFD4B Q36557606-A06B1897-7A3C-4673-A137-14F07811F054 Q36723979-2C683B17-CD5B-4E72-BFDB-D0F44D5828CB Q36922653-F94B5FAB-010F-4F29-B032-D273ED395CE4 Q36940434-4B445F87-EDD4-4AAA-92D7-5CA994E178BF Q37015715-E183CFE1-228B-48EF-8D59-E86CFAA2430E Q37432618-76774E94-D138-4011-BA2D-0E2A95BB42AC Q37628501-A0DE6177-3347-4466-95FF-0B1080D5FE31 Q37789660-F47AED94-9D7D-4F76-95DA-38B5FE858BC8

P2860

Phase II, randomized study of concomitant chemoradiotherapy followed by surgery and adjuvant capecitabine plus oxaliplatin (CAPOX) compared with induction CAPOX followed by concomitant chemoradiotherapy and surgery in magnetic resonance imaging-defi

http://www.wikidata.org/entity/Q34615588

description

2010 nî lūn-bûn

@nan

2010 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Phase II, randomized study of ...... agnetic resonance imaging-defi

@ast

Phase II, randomized study of ...... agnetic resonance imaging-defi

@en

Phase II, randomized study of ...... agnetic resonance imaging-defi

@nl

type

label

Phase II, randomized study of ...... agnetic resonance imaging-defi

@ast

Phase II, randomized study of ...... agnetic resonance imaging-defi

@en

Phase II, randomized study of ...... agnetic resonance imaging-defi

@nl

prefLabel

Phase II, randomized study of ...... agnetic resonance imaging-defi

@ast

Phase II, randomized study of ...... agnetic resonance imaging-defi

@en

Phase II, randomized study of ...... agnetic resonance imaging-defi

@nl

P1433

Q34615588-93DDD80D-38E6-4990-805D-0C6DDBA098DC

P1476

Q34615588-C96BC92F-EF07-4E5A-82A5-45F40CB9216D

P2093

Q34615588-2C24A7C2-FF3D-4B33-AEA7-ADFB71AC0723

Q34615588-3570B6E1-7BDC-4CEE-A463-29782A6606E2

Q34615588-508FBC4A-084D-4871-996C-8F0BE61893CC

Q34615588-59BFF913-E27F-4B04-8EE5-32C98E6FD863

Q34615588-5E5F367C-1E07-4574-8E15-4A4A53E17488

Q34615588-60D37D55-E765-45AD-8CBC-970CDD6CDA31

Q34615588-6512D460-C660-49AE-9BD5-1F0429AB909D

Q34615588-66AEFB6A-A9F7-4ACC-9855-1040391D3813

Q34615588-84047F8A-3CC9-49A4-B59C-BA07A23C25D5

Q34615588-8B7C06C9-C439-4784-8F2C-5B81AD35B891

P304

Q34615588-9DD13219-3313-4758-B748-CC7175BF4936

P31

Q34615588-FEB51583-DA6E-44A6-B177-426DF32D1AF6

P356

Q34615588-91BF95EC-923D-47BB-B016-0B3BAC436837

P407

Q34615588-9FDB458B-B471-453A-B8C4-994D759DAFB3

P433

Q34615588-E6E88C42-0FD5-4F98-BABB-E4031D0C7E76

P478

Q34615588-B1AFD112-9FEE-444D-A9E0-8CF64D087E96

P577

Q34615588-FBF8EBB4-4F2A-4DDB-A3FD-3E9F6EFFF2A2

P5875

Q34615588-A156D6C6-14C6-4590-9B7F-85AF96017B9C

P698

Q34615588-EA0C2400-74CE-493D-9C54-5C7DAA778916

P921

Q34615588-05DA8BFF-205E-462E-93B3-9FBB6776AB39

P356

JCO.2009.25.8541

P1433

Journal of Clinical Oncology

P1476

Phase II, randomized study of ...... agnetic resonance imaging-defi

@en

P2093

Ana Hernandez

http://www.w3.org/2001/XMLSchema#string

Antonieta Salud

http://www.w3.org/2001/XMLSchema#string

Bertomeu Massuti

http://www.w3.org/2001/XMLSchema#string

Carles Pericay

http://www.w3.org/2001/XMLSchema#string

Carlos Fernández-Martos

http://www.w3.org/2001/XMLSchema#string

Eugenio Marcuello

http://www.w3.org/2001/XMLSchema#string

Eugenio Saigi

http://www.w3.org/2001/XMLSchema#string

Fernando Arias

http://www.w3.org/2001/XMLSchema#string

Javier Serra

http://www.w3.org/2001/XMLSchema#string

Joan Maurel

http://www.w3.org/2001/XMLSchema#string

P304

859-865

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1200/JCO.2009.25.8541

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

28

http://www.w3.org/2001/XMLSchema#string

P577

2010-01-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

40907761

http://www.w3.org/2001/XMLSchema#string

P698

20065174

http://www.w3.org/2001/XMLSchema#string

P921

chemoradiotherapy